Press Release
Category Added in a WPeMatico Campaign
-
Air Products and Yara in Advanced Negotiations to Partner on Low-emission Ammonia Projects
Plans connect Air Products’ low-emission ammonia projects in the U.S. and Saudi Arabia with Yara’s world-scale ammonia network. Final Investment…
Read More » -
Goodix Powers Samsung’s Galaxy Z TriFold with Advanced Foldable Touch and Fingerprint Solutions
SHENZHEN, China, Dec. 8, 2025 /PRNewswire/ — Goodix Technology today announced that its industry‑leading main & sub touchscreen controller and…
Read More » -
The New Identity Theft Crisis: AI Scams, Child Victims, and Credit Damage Are All Spiking
Debt.com’s annual ID Theft Survey reveals that in one year, identity theft victimization rose from 43% to 78%, and concern…
Read More » -
Servier’s Voranigo® (vorasidenib) Receives Prix Galien Awards Across Multiple Regions
Voranigo® has been awarded the Prix Galien USA, the Prix Galien Poland and the Prix Galien Bridges Awards for Best Product…
Read More » -
Geleximco Group and China intelligent chassis solution provider Leekr Technology signed a MoU to deepen industrial collaboration
SHANGHAI, Dec. 8, 2025 /PRNewswire/ — Geleximco Group and Leekr Technology, a leading Chinese provider of intelligent chassis system solutions,…
Read More » -
NUNM Finalizes Campus Purchase, Strengthening Healthcare Education and Community Services in Portland
PORTLAND, Ore., Dec. 8, 2025 /PRNewswire/ — The National University of Natural Medicine (NUNM) has finalized the purchase of the…
Read More » -
Allison Worldwide Expands Global Leadership with New Europe CEO
Former Hotwire UK CEO and Edelman MD Jeremy Lucas to turbocharge Allison’s European capabilities LONDON, Dec. 8, 2025 /PRNewswire/ —…
Read More » -
Pepperstone Expands UAE Presence with SCA Category 5 Licence and New Dubai Office
DUBAI, UAE, Dec. 8, 2025 /PRNewswire/ — Pepperstone, a leading global online broker, has expanded its footprint in the UAE…
Read More » -
Ascletis’ Oral Small Molecule GLP-1, ASC30, Demonstrated Placebo-Adjusted Weight Loss of 7.7% with Better Gastrointestinal Tolerability in Its 13-Week U.S. Phase II Study in Participants with Obesity or Overweight
– ASC30 once-daily tablets showed statistically significant and clinically meaningful dose-dependent placebo-adjusted mean body weight reductions with no observed plateau…
Read More » -
Business Wire7 days ago
RWS Among First to Achieve CMMC Level 2 Certification With Perfect Score
Achievement positions RWS for key US defense contracts MAIDENHEAD, England–(BUSINESS WIRE)–RWS (RWS.L), a global AI solutions company, has achieved Level…
Read More »






